Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Dialysis Corporation of America

Holzer Holzer & Fistel, LLC is investigating whether the directors of Dialysis Corporation of America (“DCA” or the “Company”) (NASDAQ: DCAI) complied with their fiduciary duties in approving the proposed buyout of the Company by U.S. Renal Care, Inc. (“USCR”). According to the terms of the agreement announced by the companies, USRC, through a subsidiary, will commence a tender offer for the outstanding shares of DCA common stock for $11.25 per share. If a majority of DCA shares are tendered, USRC will purchase the remaining shares for the same price through a merger. The investigation seeks to determine, among other things, whether the consideration to be paid to DCA shareholders is fair and adequate.

Current holders of DCA common stock with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Dialysis OF America (NASDAQ:DCAI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024